Drug Delivery Technology
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
467
NCT02609126
Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoarthritis
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2016
Completion: Dec 28, 2017
NCT04120402
Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee
Phase: Phase 2
Start: Sep 10, 2021
Completion: Jun 1, 2023
NCT05608681
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
Phase: Phase 1/2
Start: Mar 31, 2023
Completion: Dec 31, 2026
Loading map...